메뉴 건너뛰기




Volumn 150, Issue 12, 2014, Pages 1273-1280

Association of metabolic syndrome and hidradenitis suppurativa

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 84918541605     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.1165     Document Type: Article
Times cited : (162)

References (32)
  • 1
    • 41949086822 scopus 로고    scopus 로고
    • What causes hidradenitis suppurativa?
    • Kurzen H, Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17(5):455-472
    • (2008) Exp Dermatol. , vol.17 , Issue.5 , pp. 455-472
    • Kurzen, H.1    Kurokawa, I.2    Jemec, G.B.3
  • 2
    • 84856007016 scopus 로고    scopus 로고
    • Clinical practice: Hidradenitis suppurativa
    • Jemec GBE. Clinical practice: Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158-164
    • (2012) N Engl J Med. , vol.366 , Issue.2 , pp. 158-164
    • Jemec, G.B.E.1
  • 4
    • 79955767562 scopus 로고    scopus 로고
    • Psychosocial impact of hidradenitis suppurativa: A qualitative study
    • Esmann S, Jemec GBE. Psychosocial impact of hidradenitis suppurativa: A qualitative study. Acta Derm Venereol. 2011;91(3):328-332
    • (2011) Acta Derm Venereol. , vol.91 , Issue.3 , pp. 328-332
    • Esmann, S.1    Jemec, G.B.E.2
  • 5
    • 0030434668 scopus 로고    scopus 로고
    • Hidradenitis suppurativa: Characteristics and consequences
    • Jemec GBE, HeidenheimM, Nielsen NH. Hidradenitis suppurativa: Characteristics and consequences. Clin ExpDermatol. 1996;21(6):419-423
    • (1996) Clin ExpDermatol. , vol.21 , Issue.6 , pp. 419-423
    • Jemec, G.B.E.1    Heidenheim, M.2    Nielsen, N.H.3
  • 7
    • 84873736911 scopus 로고    scopus 로고
    • Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States
    • Cosmatos I, Matcho A,Weinstein R, MontgomeryMO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;68(3):412-419
    • (2013) J Am Acad Dermatol. , vol.68 , Issue.3 , pp. 412-419
    • Cosmatos, I.1    Matcho, A.2    Weinstein, R.3    Montgomery, M.O.4    Stang, P.5
  • 8
    • 51349113269 scopus 로고    scopus 로고
    • Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
    • Revuz JE, Canoui-Poitrine F,Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies. J AmAcad Dermatol. 2008;59(4):596-601
    • (2008) J AmAcad Dermatol. , vol.59 , Issue.4 , pp. 596-601
    • Revuz, J.E.1    Canoui-Poitrine, F.2    Wolkenstein, P.3
  • 9
    • 84914161660 scopus 로고    scopus 로고
    • The prevalence of inverse recurrent suppuration: A population-based study of possible hidradenitis suppurativa
    • Vinding GR,Miller IM, Zarchi K, et al. The prevalence of inverse recurrent suppuration: A population-based study of possible hidradenitis suppurativa. Br J Dermatol. 2014;170(4):884-889
    • (2014) Br J Dermatol. , vol.170 , Issue.4 , pp. 884-889
    • Vinding, G.R.1    Miller, I.M.2    Zarchi, K.3
  • 10
    • 0029777345 scopus 로고    scopus 로고
    • The prevalence of hidradenitis suppurativa and its potential precursor lesions
    • Jemec GBE, HeidenheimM, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions.J AmAcadDermatol. 1996;35(2, pt 1):191-194
    • (1996) J AmAcadDermatol. , vol.35 , Issue.2 , pp. 191-194
    • Jemec, G.B.E.1    Heidenheim, M.2    Nielsen, N.H.3
  • 11
    • 84872196995 scopus 로고    scopus 로고
    • DavisMD. Incidence of hidradenitis suppurativa and associated factors: A population-based study of Olmsted County, Minnesota
    • Vazquez BG, Alikhan A,Weaver AL,Wetter DA, DavisMD. Incidence of hidradenitis suppurativa and associated factors: A population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2013; 133(1):97-103
    • (2013) J Invest Dermatol. , vol.133 , Issue.1 , pp. 97-103
    • Vazquez, B.G.1    Alikhan, A.2    Weaver, A.L.3    Wetter, D.A.4
  • 12
    • 84857136555 scopus 로고    scopus 로고
    • Increased prevalence of metabolic syndrome in patients with acne inversa
    • Sabat R, Chanwangpong A, Schneider-Burrus S, et al. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One. 2012;7 (2):e31810. doi:10.1371/journal.pone.0031810
    • (2012) PLoS One. , vol.7 , Issue.2 , pp. e31810
    • Sabat, R.1    Chanwangpong, A.2    Schneider-Burrus, S.3
  • 13
    • 84896084510 scopus 로고    scopus 로고
    • The prevalence of metabolic syndrome in patients with hidradenitis suppurativa
    • Gold DA, Reeder VJ, Mahan MG, et al. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. J AmAcad Dermatol. 2014;70(4):699-703
    • (2014) J Am Acad Dermatol. , vol.70 , Issue.4 , pp. 699-703
    • Gold, D.A.1    Reeder, V.J.2    Mahan, M.G.3
  • 14
    • 84887902637 scopus 로고    scopus 로고
    • Meta-Analysis of psoriasis, cardiovascular disease, and associated risk factors
    • Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-Analysis of psoriasis, cardiovascular disease, and associated risk factors. J AmAcad Dermatol. 2013;69(6):1014-1024
    • (2013) J Am Acad Dermatol. , vol.69 , Issue.6 , pp. 1014-1024
    • Miller, I.M.1    Ellervik, C.2    Yazdanyar, S.3    Jemec, G.B.4
  • 15
    • 84889062964 scopus 로고    scopus 로고
    • Quantifying cardiovascular disease risk factors in patients with psoriasis: Ameta-Analysis
    • Miller IM, Skaaby T, Ellervik C, Jemec GB. Quantifying cardiovascular disease risk factors in patients with psoriasis: Ameta-Analysis. Br J Dermatol. 2013;169(6):1180-1187
    • (2013) Br J Dermatol. , vol.169 , Issue.6 , pp. 1180-1187
    • Miller, I.M.1    Skaaby, T.2    Ellervik, C.3    Jemec, G.B.4
  • 16
    • 84887926862 scopus 로고    scopus 로고
    • Maturation of an idea: A historical perspective on the association of psoriasis with themetabolic syndrome and cardiovascular disease [letter]
    • Miller IM, Jemec GBE.Maturation of an idea: A historical perspective on the association of psoriasis with themetabolic syndrome and cardiovascular disease [letter]. Arch Dermatol. 2012;148(1):112
    • (2012) Arch Dermatol. , vol.148 , Issue.1 , pp. 112
    • Miller, I.M.1    Jemec, G.B.E.2
  • 18
    • 1842842014 scopus 로고    scopus 로고
    • Definition of metabolic syndrome: Report of the National Heart Lung and Blood Institute/ American Heart Association conference on scientific issues related to definition
    • National Heart Lung Blood Institute.American Heart Association.
    • Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; National Heart, Lung, and Blood Institute; American Heart Association. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24(2):e13-e18
    • (2004) Arterioscler Thromb Vasc Biol. , vol.24 , Issue.2 , pp. e13-e18
    • Grundy, S.M.1    Brewer, H.B.2    Cleeman, J.I.3    Smith, S.C.4    Lenfant, C.5
  • 19
    • 84883801286 scopus 로고    scopus 로고
    • Study design, participation and characteristics of the Danish General Suburban Population Study
    • Bergholdt HK, Bathum L, Kvetny J, et al. Study design, participation and characteristics of the Danish General Suburban Population Study. Dan Med J. 2013;60(9):A4693
    • (2013) Dan Med J. , vol.60 , Issue.9 , pp. A4693
    • Bergholdt, H.K.1    Bathum, L.2    Kvetny, J.3
  • 20
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497
    • (2001) JAMA. , vol.285 , Issue.19 , pp. 2486-2497
  • 21
    • 70350245011 scopus 로고    scopus 로고
    • International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association;World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute American Heart Association;World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
    • Alberti KG, Eckel RH, Grundy SM, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association;World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association;World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645
    • (2009) Circulation. , vol.120 , Issue.16 , pp. 1640-1645
    • Alberti, K.G.1    Eckel, R.H.2    Grundy, S.M.3
  • 22
    • 67650094848 scopus 로고    scopus 로고
    • International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
    • International Expert Committee.
    • International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-1334
    • (2009) Diabetes Care. , vol.32 , Issue.7 , pp. 1327-1334
  • 23
    • 84918585010 scopus 로고    scopus 로고
    • Institute for Rational Pharmacotherapy in Denmark. Guidelines on diabetes. Månedsbladet rationel farmakoterapi. 2006;8., Accessed May 21, 2014
    • Institute for Rational Pharmacotherapy in Denmark. Guidelines on diabetes. Månedsbladet rationel farmakoterapi. 2006;8.www.irf.dk. Accessed May 21, 2014
  • 24
    • 0038460302 scopus 로고    scopus 로고
    • National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report
    • Chobanian AV, Bakris GL, Black HR, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289(19):2560-2572
    • (2003) JAMA. , vol.289 , Issue.19 , pp. 2560-2572
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3
  • 25
    • 0041633576 scopus 로고    scopus 로고
    • Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa
    • Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149(1):211-213
    • (2003) Br J Dermatol. , vol.149 , Issue.1 , pp. 211-213
    • Sartorius, K.1    Lapins, J.2    Emtestam, L.3    Jemec, G.B.4
  • 26
    • 84878546337 scopus 로고    scopus 로고
    • Identification of three hidradenitis suppurativa phenotypes: Latent class analysis of a cross-sectional study
    • Canoui-Poitrine F, Le Thuaut A, Revuz JE, et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol. 2013;133(6):1506-1511
    • (2013) J Invest Dermatol. , vol.133 , Issue.6 , pp. 1506-1511
    • Canoui-Poitrine, F.1    Le Thuaut, A.2    Revuz, J.E.3
  • 27
    • 80052970269 scopus 로고    scopus 로고
    • Intensive glucose control and cardiovascular outcomes in type 2 diabetes
    • Macisaac RJ, Jerums G. Intensive glucose control and cardiovascular outcomes in type 2 diabetes. Heart Lung Circ. 2011;20(10):647-654
    • (2011) Heart Lung Circ. , vol.20 , Issue.10 , pp. 647-654
    • Macisaac, R.J.1    Jerums, G.2
  • 28
  • 29
    • 0035799806 scopus 로고    scopus 로고
    • Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
    • Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-1350
    • (2001) N Engl J Med. , vol.344 , Issue.18 , pp. 1343-1350
    • Tuomilehto, J.1    Lindström, J.2    Eriksson, J.G.3
  • 30
    • 56749106312 scopus 로고    scopus 로고
    • JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    • Ridker PM, Danielson E, Fonseca FA, et al.; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21): 2195-2207
    • (2008) N Engl J Med. , vol.359 , Issue.21 , pp. 2195-2207
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 31
    • 67650082354 scopus 로고    scopus 로고
    • Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-Analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
    • Law MR, Morris JK,Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-Analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. doi:10.1136/bmj.b1665
    • (2009) BMJ. , vol.338 , pp. b1665
    • Law, M.R.1    Morris, J.K.2    Wald, N.J.3
  • 32
    • 57149133676 scopus 로고    scopus 로고
    • Fasting and nonfasting lipid levels: Influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction
    • Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: Influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118(20):2047-2056.
    • (2008) Circulation. , vol.118 , Issue.20 , pp. 2047-2056
    • Langsted, A.1    Freiberg, J.J.2    Nordestgaard, B.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.